T. Rowe Price Associates
ATEX icon

T. Rowe Price Associates’s Anterix ATEX Stock Holding History

T. Rowe Price Associates’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.3M Buy
750,451
+742,496
+9,334% +$43.6M 0.01% 760
2026
Q1 		$304K Buy
+7,955
New +$252K ﹤0.01% 2673

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates's ATEX Position: Q2 2026 in Review

T. Rowe Price Associates increased its Anterix (ATEX) stake by 9,334% in Q2 2026, buying an estimated $43.6M and bringing the position to 750,451 shares worth $77.3M. The position accounts for 0.01% of the portfolio, ranked #760.

T. Rowe Price Associates first reported a position in ATEX in Q1 2026 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • T. Rowe Price Associates held 750,451 shares of Anterix worth $77.3M as of Q2 2026.
  • T. Rowe Price Associates bought 742,496 Anterix shares in Q2 2026, an estimated $43.6M.
  • Anterix made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #760 holding.
  • T. Rowe Price Associates first reported a position in Anterix in Q1 2026 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.